Stock comparison

JNJvsVTRS

Johnson & JohnsonvsViatris Inc. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.

JNJ

Johnson & Johnson

$230.65

+9.01%

Pharmaceuticals$585.7BNYSE

VTRS

Viatris Inc

$14.75

+26.61%

Pharmaceuticals$15.6BNASDAQ

60-day price, rebased to 100

JNJ +1.29% · VTRS +13.72%

Round-by-round

JNJ 3·VTRS 2· 1tie

EdgeVTRS

Valuation upside

-37.60% vs +97.70% to DCF fair value

EdgeJNJ

Balance-sheet strength

Altman Z 5.08 vs 0.89

Tie

Fundamental quality

Piotroski 4.00 vs 4.00 (of 9)

EdgeJNJ

Growth + margins

Rule-of-40 26.60 vs 10.00

EdgeVTRS

60-day momentum

+1.29% vs +13.72% price return

EdgeJNJ

Market-cap liquidity

$585.7B vs $15.6B

Verdict

Across6categories,JNJtakes the edge with3wins to2 (and 1 tie). Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.

Backtest a strategy onJNJorVTRS

Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.